Zacks Investment Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-14,351
| Closed | -$476K | – | 595 |
|
|
2019
Q1 | $476K | Buy |
+14,351
| New | +$476K | 0.01% | 459 |
|
|
2016
Q4 | – | Sell |
-13,256
| Closed | -$273K | – | 698 |
|
|
2016
Q3 | $273K | Buy |
+13,256
| New | +$273K | 0.01% | 515 |
|
|
2014
Q3 | – | Sell |
-11,054
| Closed | -$430K | – | 720 |
|
|
2014
Q2 | $430K | Buy |
+11,054
| New | +$430K | 0.02% | 483 |
|
|
2013
Q4 | – | Sell |
-16,088
| Closed | -$378K | – | 715 |
|
|
2013
Q3 | $378K | Sell |
16,088
-854
| -5% | -$20.1K | 0.02% | 441 |
|
|
2013
Q2 | $455K | Buy |
+16,942
| New | +$455K | 0.02% | 327 |
|